Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity

Neurochemistry International

Volumn 56, Issue 1, 2010, Pages 101-106

  Yan, Tingting ^a,c   Feng, Yan ^a,c   Zheng, Jin ^a,d   Ge, Xinjian ^a,c   Zhang, Yi ^a,c   Wu, Dongmei ^a,c   Zhao, Jian ^b   Zhai, Qiwei ^a,c  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

Axonal protection; NAD synthesis activity; Neurodegenerative disease; Wallerian degeneration

Indexed keywords

NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 1; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 2; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 3; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVE SITE; EXPLANT; GENE MUTATION; HUMAN; HUMAN CELL; MICROTUBULE; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SUPERIOR CERVICAL GANGLION; TRANSGENIC MOUSE;

ANIMALS; AXONS; CELL DEATH; CELL LINE; CELLS, CULTURED; CYTOPROTECTION; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROTUBULES; NAD; NEUROFILAMENT PROTEINS; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; RATS; RATS, SPRAGUE-DAWLEY; SUPERIOR CERVICAL GANGLION; TIME FACTORS; WALLERIAN DEGENERATION;

MAMMALIA; MUS MUSCULUS; WALLERIA;

EID: 73449100102     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.09.007     Document Type: Article

References (36)

1. Araki T., Sasaki Y., and Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305 (2004) 1010-1013
2. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., and Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1 (1991) 103-116
3. Avery M.A., Sheehan A.E., Kerr K.S., Wang J., and Freeman M.R. Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration. J. Cell. Biol. 184 (2009) 501-513
4. Balducci E., Emanuelli M., Raffaelli N., Ruggieri S., Amici A., Magni G., Orsomando G., Polzonetti V., and Natalini P. Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability. Anal. Biochem. 228 (1995) 64-68
5. Bedalov A., and Simon J.A. Neuroscience. NAD to the rescue. Science 305 (2004) 954-955
6. Beirowski B., Babetto E., Gilley J., Mazzola F., Conforti L., Janeckova L., Magni G., Ribchester R.R., and Coleman M.P. Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo. J. Neurosci. 29 (2009) 653-668
7. Berger F., Lau C., Dahlmann M., and Ziegler M. Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J. Biol. Chem. 280 (2005) 36334-36341
8. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 6 (2005) 889-898
9. Coleman M.P., and Perry V.H. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25 (2002) 532-537
10. Conforti L., Tarlton A., Mack T.G., Mi W., Buckmaster E.A., Wagner D., Perry V.H., and Coleman M.P. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 11377-11382
11. Conforti L., Wilbrey A., Morreale G., Janeckova L., Beirowski B., Adalbert R., Mazzola F., Di Stefano M., Hartley R., Babetto E., Smith T., Gilley J., Billington R.A., Genazzani A.A., Ribchester R.R., Magni G., and Coleman M. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J. Cell. Biol. 184 (2009) 491-500
12. Emanuelli M., Carnevali F., Saccucci F., Pierella F., Amici A., Raffaelli N., and Magni G. Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase. J. Biol. Chem. 276 (2001) 406-412
13. Ge X., Jin Q., Zhang F., Yan T., and Zhai Q. PCAF acetylates {beta}-catenin and improves its stability. Mol. Biol. Cell. 20 (2009) 419-427
14. Glass J.D. Wallerian degeneration as a window to peripheral neuropathy. J. Neurol. Sci. 220 (2004) 123-124
15. Hyman B.T., Van Hoesen G.W., Damasio A.R., and Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225 (1984) 1168-1170
16. Jia H., Yan T., Feng Y., Zeng C., Shi X., and Zhai Q. Identification of a critical site in Wld(s): essential for Nmnat enzyme activity and axon-protective function. Neurosci. Lett. 413 (2007) 46-51
17. Lau C., Niere M., and Ziegler M. The NMN/NaMN adenylyltransferase (NMNAT) protein family. Front Biosci. 14 (2009) 410-431
18. Liu D., Gharavi R., Pitta M., Gleichmann M., and Mattson M.P. Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med. 11 (2009) 28-42
19. MacDonald J.M., Beach M.G., Porpiglia E., Sheehan A.E., Watts R.J., and Freeman M.R. The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons. Neuron 50 (2006) 869-881
20. Mack T.G., Reiner M., Beirowski B., Mi W., Emanuelli M., Wagner D., Thomson D., Gillingwater T., Court F., Conforti L., Fernando F.S., Tarlton A., Andressen C., Addicks K., Magni G., Ribchester R.R., Perry V.H., and Coleman M.P. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 4 (2001) 1199-1206
21. Morrissette D.A., Parachikova A., Green K.N., and LaFerla F.M. Relevance of transgenic mouse models to human Alzheimer disease. J. Biol. Chem. 284 (2009) 6033-6037
22. Press C., and Milbrandt J. Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress. J. Neurosci. 28 (2008) 4861-4871
23. Raff M.C., Whitmore A.V., and Finn J.T. Axonal self-destruction and neurodegeneration. Science 296 (2002) 868-871
24. Raffaelli N., Sorci L., Amici A., Emanuelli M., Mazzola F., and Magni G. Identification of a novel human nicotinamide mononucleotide adenylyltransferase. Biochem. Biophys. Res. Commun. 297 (2002) 835-840
25. Sasaki Y., Araki T., and Milbrandt J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J. Neurosci. 26 (2006) 8484-8491
26. Sasaki Y., Vohra B.P., Lund F.E., and Milbrandt J. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J. Neurosci. 29 (2009) 5525-5535
27. Wang J., and He Z. NAD and axon degeneration: from the Wlds gene to neurochemistry. Cell Adh. Migr. 3 (2009) 77-87
28. Wang J., Zhai Q., Chen Y., Lin E., Gu W., McBurney M.W., and He Z. A local mechanism mediates NAD-dependent protection of axon degeneration. J. Cell. Biol. 170 (2005) 349-355
29. Whelan J.A., Russell N.B., and Whelan M.A. A method for the absolute quantification of cDNA using real-time PCR. J. Immunol. Methods 278 (2003) 261-269
30. Yahata N., Yuasa S., and Araki T. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration. J. Neurosci. 29 (2009) 6276-6284
31. Yalowitz J.A., Xiao S., Biju M.P., Antony A.C., Cummings O.W., Deeg M.A., and Jayaram H.N. Characterization of human brain nicotinamide 5′-mononucleotide adenylyltransferase-2 and expression in human pancreas. Biochem. J. 377 (2004) 317-326
32. Ying W. NAD+ and NADH in brain functions, brain diseases and brain aging. Front Biosci. 12 (2007) 1863-1888
33. Ying W. NAD+ and NADH in neuronal death. J. Neuroimmune Pharmacol. 2 (2007) 270-275
34. Zhai Q., Wang J., Kim A., Liu Q., Watts R., Hoopfer E., Mitchison T., Luo L., and He Z. Involvement of the ubiquitin-proteasome system in the early stages of Wallerian degeneration. Neuron 39 (2003) 217-225
35. Zhai R.G., Cao Y., Hiesinger P.R., Zhou Y., Mehta S.Q., Schulze K.L., Verstreken P., and Bellen H.J. Drosophila NMNAT maintains neural integrity independent of Its NAD synthesis activity. PLoS Biol. 4 (2006) e416
36. Zhai R.G., Zhang F., Hiesinger P.R., Cao Y., Haueter C.M., and Bellen H.J. NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration. Nature 452 (2008) 887-891